MEI Pharma Inc (NAS:MEIP)
$ 2.88 0.08 (2.86%) Market Cap: 19.19 Mil Enterprise Value: -26.23 Mil PE Ratio: 0.73 PB Ratio: 0.38 GF Score: 53/100

MEI Pharma Inc Zandelisib Program Update Webcast Transcript

Mar 24, 2022 / 08:30PM GMT
Release Date Price: $36.2 (+0.56%)
Operator

Good day, and welcome to the MEI Pharma Zandelisib Program Update Webcast. (Operator Instructions) Please note, today's event is being recorded.

I would now like to turn the conference over to David Walsey, Senior Vice President, Corporate Affairs at MEI Pharma. Please go ahead, sir.

David A. Walsey
MEI Pharma, Inc. - SVP of Corporate Affairs

Thank you, and thanks, everyone, for joining our webcast today.

Before we get started, I want to call your attention to the fact that this conference call may contain certain forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. You should be aware that our actual results could differ materially from those contained in our forward-looking statements, which are based on management's current expectations and are subject to a number of risks and uncertainties as discussed in our SEC filings, including our most recent annual report on Form 10-K filed for the period ending June 30, 2021, and our quarterly reports on Form 10-Q

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot